Background illustration for clinical trials search

Paid Clinical Trials New Braunfels

Discover 1,413 paid clinical trials in New Braunfels, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,413

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

for

Colitis, Ulcerative

Location: San Antonio TX, Tyler TX, Lafayette LA,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07577856

Phase3, Recruiting

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

for

Crohn Disease

Location: San Antonio TX, Topeka KS, St Louis MO, Englewood CO,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07483099

Phase2, Recruiting

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

for

Colitis, Ulcerative, Crohn Disease

Location: San Antonio TX, Topeka KS, St Louis MO, Englewood CO,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07483073

Phase2, Recruiting

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)

for

Irritable Bowel Syndrome, Constipation

Location: San Antonio TX, Webster TX, McAllen TX, Mesa AZ,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07545772

Phase2, Recruiting

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)

for

Irritable Bowel Syndrome, Diarrhea

Location: San Antonio TX, McAllen TX, Mesa AZ, Springfield IL,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07545759

Phase2, Recruiting

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

for

Crohn Disease

Location: San Antonio TX, Austin TX, Houston TX, Dallas TX,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07196722

Phase2, Phase3, Recruiting

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

for

Colitis, Ulcerative

Location: San Antonio TX, Austin TX, Houston TX, Southlake TX,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 12+

Code: NCT07196748

Phase3, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for

Hepatocellular Carcinoma

Location: San Antonio TX, Austin TX, Houston TX, Tyler TX,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase3, Recruiting

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

for

Advanced Breast Cancer

Location: San Antonio TX, Houston TX, Springfield MO,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06380751

Phase3, Recruiting

Mirikizumab Real World Protocol

for

Ulcerative Colitis

Location: San Antonio TX, Denver CO, Iowa City IA, Louisville KY,

Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18+

Code: NCT06696014

Recruiting

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for

Endometrial Cancer

Location: San Antonio TX, Austin TX, Houston TX, Fort Worth TX,

Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT06989112

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

for

Crohn's Disease

Location: San Antonio TX, Houston TX, Mansfield TX, Denton TX,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 16 - 70+

Code: NCT06430801

Phase3, Recruiting

Cognitive Screening Made Easy for PCPs - Administrative Supplement

for

Cognitive Impairment, Cognitive Decline, Dementia, Mild

Location: San Antonio TX, Austin TX

Sponsor: University of Texas at Austin

Sex: All

Age: 60+

Code: NCT06928298

Recruiting

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

for

Narcolepsy Type 1

Location: San Antonio TX, Birmingham AL, Colorado Springs CO,

Sponsor: Takeda

Sex: All

Age: 16 - 70

Code: NCT05816382

Phase2, Phase3, Recruiting

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

for

Obesity, Obstructive Sleep Apnea

Location: San Antonio TX, Austin TX, DeSoto TX, Atlanta GA,

Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07225686

Phase3, Recruiting

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

for

Metastatic Castration-Resistant Prostate Cancer

Location: San Antonio TX, Little Rock AR, Fayetteville AR,

Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT06629779

Phase3, Recruiting

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

for

Type 1 Diabetes

Location: San Antonio TX, Houston TX, Fort Worth TX, Dallas TX,

Sponsor: SAb Biotherapeutics, Inc.

Sex: All

Age: 5 - 40

Code: NCT07187531

Phase2, Recruiting

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

for

Non-Muscle Invasive Bladder Neoplasms

Location: San Antonio TX, Austin TX, Lafayette LA, Germantown TN,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06919965

Phase3, Recruiting

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

for

Metastatic Castration-resistant Prostate Cancer,

Location: San Antonio TX, Rochester MN, Madison WI,

Sponsor: K36 Therapeutics, Inc.

Sex: Male

Age: 18+

Code: NCT07103018

Phase1, Recruiting

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

for

Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma

Location: San Antonio TX, Austin TX, Houston TX, The Woodlands TX,

Sponsor: UroGen Pharma Ltd.

Sex: All

Age: 18+

Code: NCT06774131

Phase3, Recruiting

Paid Clinical Trials New Braunfels

Filter results

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)

Interested in new trials?

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

Mirikizumab Real World Protocol

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Cognitive Screening Made Easy for PCPs - Administrative Supplement

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer